[VIVO] YoY Quarter Result on 30-Jun-2021 [#Q3]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
06-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q3]
Profit Trend
QoQ- -55.63%
YoY- -57.58%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 67,771 63,511 84,797 48,440 51,737 50,140 50,665 4.96%
PBT -6,602 15,295 34,873 6,478 8,620 3,946 13,401 -
Tax 736 3,626 7,366 1,399 1,795 3,706 4,647 -26.43%
NP -7,338 11,669 27,507 5,079 6,825 240 8,754 -
Tax Rate - -23.71% -21.12% -21.60% -20.82% -93.92% -34.68% -
Total Cost 75,109 51,842 57,290 43,361 44,912 49,900 41,911 10.20%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -10.83 18.37 32.44 10.49 13.19 0.48 17.28 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.16 0.27 0.64 0.12 0.16 0.01 0.21 -
EPS Diluted -0.16 0.26 0.64 0.12 0.16 0.01 0.21 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.